Sign in

CIK 0001372299

  • Non-accelerated filer
  • Smaller reporting company

Ocugen, Inc.

Sign in to watch
Ticker
OCGN
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 484-328-4701
Business address
11 GREAT VALLEY PARKWAY, MALVERN, PA, 19355
Former names
HISTOGENICS CORP
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$1,088,801
in 2 filings, $1.1M under 10b5-1 plans

Net −$1,088,801. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Musunuri Shankar −$1.1M Chief Executive Officer sold 51% of stake
Date Insider Transaction Shares Price Value Owned after
2018-06-15 GILL DAVID N Director Grant or award · Stock Option (Right to Buy) +25,000 25,000
2017-08-16 GILL DAVID N Director Purchase +3,000 $1.81 $5K 14,000
2017-06-13 GILL DAVID N Director Grant or award · Stock Option (Right to Buy) +25,000 25,000
2017-05-16 GILL DAVID N Director Purchase +3,000 $1.68 $5K 11,000
2016-12-16 GILL DAVID N Director Grant or award · Stock Option (Right to Buy) +10,000 10,000
2016-12-15 GILL DAVID N Director Purchase +3,000 $1.65 $5K 8,000
2016-12-09 GILL DAVID N Director Purchase +5,000 $1.92 $10K 5,000
2015-06-24 GILL DAVID N Director Grant or award · Stock Option (Right to Buy) +6,800 6,800
2015-02-02 GILL DAVID N Director Grant or award · Employee Stock Option (Right to Buy) +13,200 13,200

Page 1 of 1 · 9 trades